Two Sigma Investments
SWTX

Two Sigma Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Two Sigma Investments’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-153,365
Closed -$4.91M – 3474
2024
Q3 		$4.91M Sell
153,365
-40,790
-21% -$1.52M 0.01% 1102
2024
Q2 		$7.31M Buy
194,155
+178,050
+1,106% +$7.49M 0.02% 829
2024
Q1 		$793K Sell
16,105
-45,281
-74% -$2.09M ﹤0.01% 2095
2023
Q4 		$2.24M Buy
61,386
+9,586
+19% +$250K 0.01% 1444
2023
Q3 		$1.2M Sell
51,800
-2,100
-4% -$57.4K ﹤0.01% 1832
2023
Q2 		$1.41M Sell
53,900
-21,600
-29% -$568K ﹤0.01% 1732
2023
Q1 		$1.94M Sell
75,500
-43,267
-36% -$1.26M 0.01% 1400
2022
Q4 		$3.09M Buy
118,767
+3,068
+3% +$75.6K 0.01% 1099
2022
Q3 		$3.3M Sell
115,699
-206,993
-64% -$5.93M 0.01% 931
2022
Q2 		$7.95M Buy
+322,692
New +$11.8M 0.03% 588
2022
Q1 		– Sell
-78,250
Closed -$4.85M – 4215
2021
Q4 		$4.85M Sell
78,250
-67,971
-46% -$4.5M 0.01% 1213
2021
Q3 		$9.28M Buy
146,221
+129,757
+788% +$10M 0.02% 806
2021
Q2 		$1.36M Sell
16,464
-38,619
-70% -$2.93M ﹤0.01% 2211
2021
Q1 		$4.05M Buy
55,083
+23,653
+75% +$1.85M 0.01% 1189
2020
Q4 		$2.28M Buy
+31,430
New +$2.02M 0.01% 1412

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Two Sigma Investments's SWTX Position: Q4 2024 in Review

Two Sigma Investments sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 153,365 shares — an estimated $4.91M sold.

Two Sigma Investments first reported a position in SWTX in Q4 2020 and held it in 15 quarters. The position peaked at $9.28M in Q3 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.

  • Two Sigma Investments reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 153,365 SpringWorks Therapeutics shares in Q4 2024, an estimated $4.91M.
  • Two Sigma Investments first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 15 quarters.
  • Two Sigma Investments's SpringWorks Therapeutics position peaked at $9.28M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.